|
VPS13D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.733950E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.101600E-02 |
| Normal-vs-Stage2 |
9.943800E-01 |
| Normal-vs-Stage3 |
3.005200E-01 |
| Normal-vs-Stage4 |
2.696100E-02 |
| Stage1-vs-Stage2 |
2.236000E-01 |
| Stage1-vs-Stage3 |
5.347200E-01 |
| Stage1-vs-Stage4 |
1.056160E-01 |
| Stage2-vs-Stage3 |
4.628000E-01 |
| Stage2-vs-Stage4 |
3.710400E-02 |
| Stage3-vs-Stage4 |
7.094400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.803900E-02 |
| Normal-vs-AfricanAmerican |
7.945800E-02 |
| Normal-vs-Asian |
1.835690E-02 |
| Caucasian-vs-AfricanAmerican |
1.727010E-01 |
| Caucasian-vs-Asian |
1.387760E-01 |
| AfricanAmerican-vs-Asian |
8.339000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.018400E-02 |
| Normal-vs-Female |
5.740100E-02 |
| Male-vs-Female |
2.990600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.238700E-03 |
| Normal-vs-Age(41-60Yrs) |
4.919600E-02 |
| Normal-vs-Age(61-80Yrs) |
2.311400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.117970E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.555000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.261400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.181700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.341600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.035900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.047660E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.782000E-01 |
| Classical-VS-Follicular |
1.70600000792831E-09 |
| Classical-VS-Other |
1.196620E-01 |
| Classical-VS-Normal |
8.38810000000079E-05 |
| Tall-VS-Follicular |
1.004470E-03 |
| Tall-VS-Other |
1.037250E-01 |
| Tall-VS-Normal |
8.643800E-02 |
| Follicular-VS-Other |
9.180000E-01 |
| Follicular-VS-Normal |
1.026120E-02 |
| Other-VS-Normal |
2.121600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.538600E-01 |
| Normal-vs-N1 |
2.896400E-01 |
| N0-vs-N1 |
3.993200E-01 |
|
|
